Proteolytic cleavage of recombinant two-chain factor VIII during cell culture production is mediated by protease(s) from lysed cells. The use of pulse labelling directly in production medium
- PMID: 22358766
- PMCID: PMC3449617
- DOI: 10.1023/A:1007988713571
Proteolytic cleavage of recombinant two-chain factor VIII during cell culture production is mediated by protease(s) from lysed cells. The use of pulse labelling directly in production medium
Abstract
During the production by mammalian cells of recombinant factor VIII from which the B domain was deleted (rFVIII), proteolytic cleavages in the C-terminal part of the heavy chain were observed (Kjalke et al., 1995). By radioactive pulse labelling it was investigated whether the cleavages took place inside the cells during protein synthesis or after release in the medium. The rFVIII-producing CHO (Chinese hamster ovary) cells were cultured in the presence of (35)S-methionine and then the cell lysate and the conditioned media were immunoprecipitated and analyzed by electrophoresis. By pulse labelling and chasing for various time periods, it was shown that the cleavages only took place after secretion of the protein from the cells. Adding cell lysate to uncleaved rFVIII caused cleavage of the heavy chain, as seen by loss of binding to a monoclonal antibody specific for intact rFVIII, indicating that the cleavage was performed by proteinase(s) released from the lysed cells. By incubating intact rFVIII with the multicatalytic proteinase (proteasome) present in cytoplasm and nucleus of eukaryotic cells, loss of binding to the monoclonal antibody was observed. This indicates that the multicatalytic proteinase, released from lysed rFVIII producing cells, could be responsible for the cleavage of rFVIII. Among several protease inhibitors tested, only bacitracin was found to diminish the extent of cleavage. Phosphatidylserine also protected rFVIII against cleavage, probably by binding to rFVIII.
Similar articles
-
Enhanced Proteolytic Processing of Recombinant Human Coagulation Factor VIII B-Domain Variants by Recombinant Furins.Mol Biotechnol. 2016 Jun;58(6):404-14. doi: 10.1007/s12033-016-9939-9. Mol Biotechnol. 2016. PMID: 27126696
-
Physicochemical characterisation of rVIII-SingleChain, a novel recombinant single-chain factor VIII.Thromb Res. 2015 Aug;136(2):388-95. doi: 10.1016/j.thromres.2015.05.005. Epub 2015 May 16. Thromb Res. 2015. PMID: 26037285
-
Optimisation of the Factor VIII yield in mammalian cell cultures by reducing the membrane bound fraction.J Biotechnol. 2011 Feb 20;151(4):357-62. doi: 10.1016/j.jbiotec.2010.12.019. Epub 2011 Jan 8. J Biotechnol. 2011. PMID: 21219947
-
Expression of factor VIII in recombinant and transgenic systems.Blood Cells Mol Dis. 2002 Mar-Apr;28(2):234-48. doi: 10.1006/bcmd.2002.0508. Blood Cells Mol Dis. 2002. PMID: 12064919 Review.
-
Baby hamster kidney cell-derived recombinant factor VIII: a quarter century of learning and clinical experience.Expert Rev Hematol. 2016 Dec;9(12):1151-1164. doi: 10.1080/17474086.2017.1259559. Epub 2016 Nov 28. Expert Rev Hematol. 2016. PMID: 27841041 Review.
Cited by
-
Recombinant interferon-gamma secreted by Chinese hamster ovary-320 cells cultivated in suspension in protein-free media is protected against extracellular proteolysis by the expression of natural protease inhibitors and by the addition of plant protein hydrolysates to the culture medium.In Vitro Cell Dev Biol Anim. 2005 Mar-Apr;41(3-4):83-91. doi: 10.1290/0411075.1. In Vitro Cell Dev Biol Anim. 2005. PMID: 16029078
-
Combination of yeast hydrolysates to improve CHO cell growth and IgG production.Cytotechnology. 2013 Aug;65(4):629-41. doi: 10.1007/s10616-012-9519-1. Epub 2012 Dec 14. Cytotechnology. 2013. PMID: 23239488 Free PMC article.
References
-
- Ezban M, Chapman B, Petersen J, Hansen K, Rasmussen PB, Thomsen J, Kjalke M, Kongerslev L. Characterization of recombinant human two-chain factor VIII. Thromb. Hemostasis. 1993;69:1088.
-
- Froud SJ, Clements GJ, Doyle ME, Harris ELV, Lloyd C, Murray P, Preneta PE, Stephens PE, Thomsen S, Yarranton GT, et al. The development of a process for the production of HIV1 GP120 from recombinant cell lines. In: Spier RE, et al., editors. Production of Biologicals from animal cells in culture. Oxford: Butterworth-Heinemann; 1991. pp. 110–114.
-
- Hames BD. Preparation and electrophoresis of polyacrylamide gels. In: Hames BD, Rickwood D., editors. Gel electrophoresis of proteins. A practical approach. Oxford: Oxford University Press; 1990. pp. 30–50.
LinkOut - more resources
Full Text Sources
Other Literature Sources